Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab study is displayed, with details on the trial design, participant criteria, study locations, outcome measures, investigators, and data-sharing plans.
    Difference
    46%
    Check dated 2026-11-09T13:19:53.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2. The study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:18:35.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A notice appears above the study record stating that NIH websites are transitioning and that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence,” with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:13:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:02.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:45:57.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the study information, blocking access to the NCT03832569 details and related content while the site chrome remains visible.
    Difference
    17%
    Check dated 2026-09-21T20:24:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.